Pharmacological Approaches in Managing Symptomatic Relief of Benign Prostatic Hyperplasia: A Comprehensive Review

    December 2023 in “ Curēus ”
    Collyn O’Quin, Kathryn White, John R. Campbell … Alan D. Kaye
    Studysummary This literature review identified that phosphodiesterase 5 inhibitors, such as Tadalafil, are highly effective in improving lower urinary tract symptoms associated with benign prostatic hyperplasia, while the efficacy of saw palmetto remains inconsistent.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on assets.cureus.com →
    Discuss this study in the Community →

    Research cited in this study 2

    1. What Do We Know About Phytotherapy of Benign Prostatic Hyperplasia? Life Sciences · 2015
    2. A Comparison of Varying Alpha-Blockers and Other Pharmacotherapy Options for Lower Urinary Tract Symptoms PubMed · 2005